Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | iExosomes |
| Synonyms | |
| Therapy Description |
iExosomes are exosomes engineered to deliver siRNA against KRAS G12D to tumor cells, potentially leading to increased apoptosis of KRAS G12D-mutant tumor cells and decreased tumor growth (PMID: 29669940). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| iExosomes | iExosomes are exosomes engineered to deliver siRNA against KRAS G12D to tumor cells, potentially leading to increased apoptosis of KRAS G12D-mutant tumor cells and decreased tumor growth (PMID: 29669940). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03608631 | Phase I | iExosomes | IExosomes in Treating Participants with Metastatic Pancreas Cancer with KrasG12D Mutation | Recruiting | USA | 0 |